Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anura Indulkar

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine|September 17, 2013
Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administrationSanyog Jain, Harshad Harde, Anura Indulkar, et al.
Journal of Biomedical Nanotechnology|April 23, 2014
Oral mucosal immunization using glucomannosylated bilosomesSanyog Jain, Anura Indulkar, Harshad Harde, et al.
Molecular Pharmaceutics|May 1, 2026
The In Vivo Effect of Amorphous Drug Nanoprecipitates on the Intestinal Absorption of the PROTACs ARV-110 (Bavdeglutamide) and ARV-471 (Vepdegestrant)Janis Niessen, Mirko Koziolek, Anura Indulkar, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 12, 2024
Development and validation of LC-MS/MS methods for the pharmacokinetic assessment of the PROTACs bavdeglutamide (ARV-110) and vepdegestrant (ARV-471)Janis Niessen, Jenny M Nilsson, Karsten Peters, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 14, 2025
A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in ratsJanis Niessen, Nathalie Arendt, Markus Sjöblom, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nanomedicine : Nanotechnology, Biology, and Medicine|September 17, 2013
Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administrationSanyog Jain, Harshad Harde, Anura Indulkar, et al.
Journal of Biomedical Nanotechnology|April 23, 2014
Oral mucosal immunization using glucomannosylated bilosomesSanyog Jain, Anura Indulkar, Harshad Harde, et al.
Molecular Pharmaceutics|May 1, 2026
The In Vivo Effect of Amorphous Drug Nanoprecipitates on the Intestinal Absorption of the PROTACs ARV-110 (Bavdeglutamide) and ARV-471 (Vepdegestrant)Janis Niessen, Mirko Koziolek, Anura Indulkar, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 12, 2024
Development and validation of LC-MS/MS methods for the pharmacokinetic assessment of the PROTACs bavdeglutamide (ARV-110) and vepdegestrant (ARV-471)Janis Niessen, Jenny M Nilsson, Karsten Peters, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 14, 2025
A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in ratsJanis Niessen, Nathalie Arendt, Markus Sjöblom, et al.
Pageof 1